期刊文献+

放化疗作用相关通路基因多态性与局部区域晚期鼻咽癌预后的关系 被引量:2

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in locoregionally advanced nasopharyngeal carcinoma
原文传递
导出
摘要 目的:探讨放化疗作用相关通路基因多态性与初治局部区域晚期鼻咽癌患者预后的关系。方法:入组203例局部区域晚期鼻咽癌患者。检测属于放化疗通路或顺铂/氟尿嘧啶通路的13个基因、18个位点的单核苷酸多态性(SNP),采用Kaplan-Meier法进行生存分析,Cox回归进行多因素分析。结果:Kaplan-Meier分析显示,携带rs25487AA、rs1136410CC+TT基因型的患者总生存率降低;携带rs2032582AT基因型的患者无局部区域复发生存率降低;携带rs25487AA、rs2010963CC、rs833061CT+TT基因型的患者无远处转移生存率降低;携带rs3212986GG、rs25487AA、rs2032582AT、rs2279744GG+GT基因型的患者无进展生存率降低。Cox分析显示,上述位点除rs833061CT+TT基因型外,均为预后的独立危险因素(P<0.05)。结论:放化疗作用相关通路中的多个SNP是影响局部区域晚期鼻咽癌的独立预后因素,为鼻咽癌的个体化治疗和判断预后提供了参考指标。 OBJECTIVE:To investigate the correlation between the gene polymorphisms of radiotherapy,chemotherapy action pathways and the prognosis of the patients with locoregionally advanced nasopharyngeal carcinoma(NPC).METHODS:A total of 203 locoregionally advanced NPC patients were enrolled in the study.18 single nucleotide polymorphisms(SNPs)belong to 13 genes in the radiotherapy and chemotherapy action pathways were examined.Kaplan-Meier method and Cox regression model were employed for analysis.RESULTS:Kaplan-Meier analysis showed that the patients carried rs25487 AA,rs1136410 CC+TT genotypes had lower OS(overall survival rates);the patients carried rs2032582 AT genotype had lower LRFS(locoregional relapse free survival rates);the patients carried rs25487 AA,rs2010963 CC,rs833061 CT+TT genotypes had lower DMFS(distant metastasis free survival rates);the patients carried rs3212986 GG,rs25487 AA,rs2032582 AT,rs2279744 GG+GT genotypes had lower PFS(progress free survival rates).Cox analysis showed that the aforementioned SNPs were the independent influence factors to the correspondingly survival rates except rs833061(P〈0.05).CONCLUSION:A few SNPs in radiotherapy or chemotherapy action pathways are prognostic factors for patients with locoregionally advanced NPC,which provided new molecular factors to evaluate the prognosis and perform individualized treatments.
出处 《中华肿瘤防治杂志》 CAS 2010年第10期755-758,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30600755) "863计划"子课题(2006AA02A404) 广东省科委项目(2007B060401064) 广东省医学科研基金(B2006063) 广州市科委项目(2007Z1-E4022)
关键词 鼻咽肿瘤/放射疗法 化学治疗 基因 单核苷酸多态性 预后 nasopharyngeal neoplasms/radiotherapy chemotherapy gene single nucleotide polymorphism prognosis
  • 相关文献

参考文献14

  • 1Al-Sarraf M, Le Blanc M, Girl P G, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ⅲ randomized Intergroup study 0099[J]. J Clin Oncol, 1998,16 (4) : 1310-1317.
  • 2Huang Z H, Hua D, Li LH, et al. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population[J]. Cancer Chemother Pharmacol,2009,63(5) :911-918.
  • 3Huang M Y, Wang Y H, Chen F M, et al. Multiple Genetic Polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC highly correlated with early relapse of breast cancer patients in Taiwan[J]. Ann Surg Oncol,2008,15(3) :872-880.
  • 4Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta analysis of eight randomized trials and 1753 paticnts[J]. Int J Radiat Oncol Biol Phys,2006,64(1) :47-56.
  • 5Lin J C, Liang W M,Jan J S,et al. Another way to estimate outcome of advanced nasopharyngeal carcinoma is concurrent chemoradiotherapy adequate[J]. Int J Radiat Oncol Biol Phys, 2004,60(1) :156-164.
  • 6Bartek J, Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage[J]. Curr Opin Cell Biol,2001,13(6) :738-747.
  • 7McKean-Cowdin R, Bamholtz Sloan J, Inskip P D, et al. Associations between polymorphisms in DNA repair genes and glioblastoma [J]. Cancer Epidemiol Biomarkers Prey,2009,18(4):1118-1126.
  • 8Nelson H H, Bagnato A, Battistini B, et al. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction [J]. Cancer Res, 2002,62(1) : 152-155.
  • 9Gottesman M M. Mechanisms of cancer drug resistance[J]. Annu Rev Med,2002,53:615-627.
  • 10Hoffmeyer S; Burk Q, yon Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo[J]. Proc Natl Acad Sci U S A,2000,97(7): 3473-3478.

同被引文献35

  • 1张帅,肖健云,田勇泉,赵素萍,邱元正,王承龙.凋亡抑制基因Survivin与鼻咽癌预后关系的研究[J].中国耳鼻咽喉颅底外科杂志,2004,10(4):196-199. 被引量:17
  • 2Ambrosini G, Adida C, Alteri DC. A novel anti-apotosis gene, Surviving, express in cancer and lymphoma[J]. Nature Med,1997, (8): 917-921.
  • 3Cryns V, Yuan Y. Proteases to die for [J]. Genes Dev, 1999, 12(11): 1551-1570.
  • 4Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis [J]. Genes Dev, 1999, 13(3): 239-252.
  • 5Dong Y, Sui L, Watanabe Y, et al. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications [J]. Anticancer Res, 2002, 22(4): 2377-2383.
  • 6Adida C, Berrebi D, Peuchmaur M, et al. Anti-apoptosis gene, survivin, and prognosis ofneuroblastoma [letter] [J]. Lancet, 1998, 351 (9106): 882-883.
  • 7Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res, 2000, 6(6): 127-134.
  • 8Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas [J]. Cancer Res, 1998, 58(9): 1808-1812.
  • 9Shin S, Sung B J, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and caspase-7 [J]. Biochemistry, 2001,40(4) : 1117-1123.
  • 10Kato J, Kuwabara Y, Mitani M, et al. Expression of Survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy [J]. Int J Cancer, 2001, 95(2): 92-95.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部